NCT03745729View on ClinicalTrials.gov

Allopurinol in Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Acute Coronary Syndrome
Interventions
DRUG

allopurinol sustained-release capsules

allopurinol sustained-release capsules (0.25g), once a day, one pill at a time

DRUG

placebo capsules

placebo sustained-release capsules, once a day, one pill at a time

Trial Locations (1)

430022

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT03745729 - Allopurinol in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter